Galera Therapeutics, LLC., a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics that have the potential to transform radiotherapy in cancer, has appointed an accomplished pharmaceutical sales, market access, and commercial operations executives to Galera’s senior commercial leadership team, effective immediately. Under the direction of Mark Bachleda, Galera’s chief commercial officer, the team will be responsible for building out the Company’s comm...